Svetlana Nikic, Founder of Precision Oncology Consulting, shared on LinkedIn:
“Navigating congress program is not always easy!
So if you’re heading to ESMO26 in Madrid later this month, and are working in the space of minimal residual disease and comprehensive genomic profiling, here’s a list that might come in handy.
My team has reviewed the posters that will be presented at ESMO and sorted them according to cancer type and whether they’re looking into clinical utility, implementation, validity etc. We’ve done a short overview of some of the companies and the data they’ll present (Tempus AI, Natera, Guardant Health, Foundation Medicine) – This is probably not complete and we will keep an eye on press releases from leading Dx companies which will be coming out these days.
Feel free to message in comment section the press releases that we should include in our future ESMO26 insights.
We hope this is useful!
Please share and follow me Svetlana Nikic, and my team at Precision Oncology Consulting if you’re interested in this type of pre- and also post-congress insights.”
You can also read: OncoDaily at ESMO 2026: Where Science Meets Community
